Home | My Profile | Contact Us
Research Trends Products  |   order gateway  |   author gateway  |   editor gateway  
Register | Forgot Password

Author Resources
 Author Gateway
 Article submission guidelines

Editor Resources
 Editor/Referee Gateway

 Regional Subscription Agents/Distributors
Current Topics in Virology   Volumes    Volume 14 
The engineering, use, and mass production of adeno-associated virus as a vector for gene therapy
Ryan Kligman, Renald Gilbert, Amine Kamen
Pages: 1 - 16
Number of pages: 16
Current Topics in Virology
Volume 14 

Copyright © 2017 Research Trends. All rights reserved

In recent years, building on a new understanding of cellular biology and human genomics, gene therapy has emerged as a new potential treatment option for both monogenic and complex disorders. Currently, the most successful and researched gene therapeutic vector is the adeno-associated virus (AAV) due to many of its characteristics, which make it a safe and effective gene delivery system. However, one issue impeding its widespread clinical translation has been the extremely large dosages required for an effective therapeutic benefit. A consequence of the need for such high doses is the necessity for large production yields. If this obstacle can be overcome, the use of AAV for gene therapy will likely proceed at an unprecedented rate. This review discusses the use of AAV as a viral vector, including its clinical successes to date, its biology, vector design strategies, the costs and benefits of the most popular production techniques, and a brief discussion of purification strategies.
View Full Article  


Buy this article
Buy this volume
Subscribe to this title
Shopping Cart

Quick Links
Search Products
Browse in Alphabetical Order : Journals
Browse by Subject Classification : Journals

Ordering Information Ordering Information
Downloadable forms Downloadable Forms